Skip to main content
Top
Published in:

22-04-2022

A dynamic model of price competition and promotion in prescription drug markets

Author: Abhik Roy

Published in: Marketing Letters | Issue 4/2022

Log in

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

In prescription drug markets, the effects of advertising on demand for the drug category and for specific brands have been studied, and the interaction between price and non-price promotions, acting on demand for the drug, is well established. More recently, supply-side decisions such as competitive pricing strategies between rival firms in the same therapeutic category, and the interaction between them and consumer advertising have been examined. The study extends the research on the relationship between competitive pricing strategies and direct-to-consumer advertising (DTCA) by developing and estimating a dynamic model in which sales is influenced by a combination of consumer advertising, detailing, and pricing. The model is estimated using US data from two medical therapeutic categories. One of these datasets has been used in estimation of a static model in a recently published study, and we compare the results of our dynamic model with the static model results. A dynamic model is appropriate for a market where there is a limited period and planning horizon for recovering the costs of drug development before a branded prescription drug loses its patent protection. The relationship between DTCA, detailing, and pricing under different competitive strategies is examined empirically. It is found that the dynamic model can contradict a basic conclusion of a static model, regarding mode of competitive pricing behavior. The relationship between amount and type of DTCA and competitive pricing strategy is as found in previous studies. There are implications for the marketing of pharmaceutical brands during their period of patent protection.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Appendix
Available only for authorised users
Literature
go back to reference Akaike, H. (1974). A new look at the statistical model identification. IEEE Transactions on Automatic Control, 19, 716–723.CrossRef Akaike, H. (1974). A new look at the statistical model identification. IEEE Transactions on Automatic Control, 19, 716–723.CrossRef
go back to reference Ailawadi, K., Kopalle, P., & Neslin, S. (2005). Predicting competitive response to a major policy change; Combining game-theoretic and empirical analysis. Marketing Science, 24, 12–24.CrossRef Ailawadi, K., Kopalle, P., & Neslin, S. (2005). Predicting competitive response to a major policy change; Combining game-theoretic and empirical analysis. Marketing Science, 24, 12–24.CrossRef
go back to reference Amaldoss, W., & He, C. (2009). Direct-to-consumer advertising of prescription drugs: A strategic analysis. Marketing Science, 28, 472–487.CrossRef Amaldoss, W., & He, C. (2009). Direct-to-consumer advertising of prescription drugs: A strategic analysis. Marketing Science, 28, 472–487.CrossRef
go back to reference Bala, R. P., & Bhardwaj, P. (2010). Detailing vs. direct-to-consumer advertising in the prescription pharmaceutical industry. Management Science, 56, 148–160.CrossRef Bala, R. P., & Bhardwaj, P. (2010). Detailing vs. direct-to-consumer advertising in the prescription pharmaceutical industry. Management Science, 56, 148–160.CrossRef
go back to reference Chintagunta, P. K., & Desiraju, R. (2005). Strategic pricing and detailing behavior in international markets. Marketing Science, 24, 167–180.CrossRef Chintagunta, P. K., & Desiraju, R. (2005). Strategic pricing and detailing behavior in international markets. Marketing Science, 24, 167–180.CrossRef
go back to reference Cyrenne, P. (1997). Price leadership and vertical relationships. Canadian Journal of Economics, 30, 235–245.CrossRef Cyrenne, P. (1997). Price leadership and vertical relationships. Canadian Journal of Economics, 30, 235–245.CrossRef
go back to reference Deneckere, R., Kovenock, R. D., & Lee, R. (1992). A model of price leadership based on consumer loyalty. The Journal of Industrial Economics, 40, 147–154.CrossRef Deneckere, R., Kovenock, R. D., & Lee, R. (1992). A model of price leadership based on consumer loyalty. The Journal of Industrial Economics, 40, 147–154.CrossRef
go back to reference Dowrick, S. (1986). von Stackelberg and Cournot duopoly: Choosing roles. The RAND Journal of Economics, 17, 251–261.CrossRef Dowrick, S. (1986). von Stackelberg and Cournot duopoly: Choosing roles. The RAND Journal of Economics, 17, 251–261.CrossRef
go back to reference Fischer, M., & Albers, S. (2010). Patient- or physician-oriented marketing: What drives primary demand for prescription drugs? Journal of Marketing Research, 47, 103–121.CrossRef Fischer, M., & Albers, S. (2010). Patient- or physician-oriented marketing: What drives primary demand for prescription drugs? Journal of Marketing Research, 47, 103–121.CrossRef
go back to reference Gal-Or, E. (1985). Information sharing in oligopoly. Econometrica, 53, 329–343.CrossRef Gal-Or, E. (1985). Information sharing in oligopoly. Econometrica, 53, 329–343.CrossRef
go back to reference Hausman, J. A. (1978). Specification tests in econometrics. Econometrica, 46, 1251–1271.CrossRef Hausman, J. A. (1978). Specification tests in econometrics. Econometrica, 46, 1251–1271.CrossRef
go back to reference Mintzes, B., Barer, M. L., Kravitz, R. L., Bassett, B., Lexchin, J., Kazanjian, A., Evans, R. G., Pan, R., & Marion, S. A. (2003). How does direct-to-consumer Advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. Canadian Medical Association Journal, 50, 1704–1715. Mintzes, B., Barer, M. L., Kravitz, R. L., Bassett, B., Lexchin, J., Kazanjian, A., Evans, R. G., Pan, R., & Marion, S. A. (2003). How does direct-to-consumer Advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. Canadian Medical Association Journal, 50, 1704–1715.
go back to reference Mukherji, P., Janakiraman, R., Dutta, S., & Rajiv, S. (2017). How direct-to-consumer advertising for prescription drugs affects consumers’ welfare: A natural experiment tests the impact of FDA legislation. Journal of Advertising Research, 57, 194–208.CrossRef Mukherji, P., Janakiraman, R., Dutta, S., & Rajiv, S. (2017). How direct-to-consumer advertising for prescription drugs affects consumers’ welfare: A natural experiment tests the impact of FDA legislation. Journal of Advertising Research, 57, 194–208.CrossRef
go back to reference Narayanan, S., Desiraju, R., & Chintagunta, P. K. (2004). Return on investment implications for pharmaceutical promotional expenditures: The role of marketing-mix interactions. Journal of Marketing, 68, 490–505.CrossRef Narayanan, S., Desiraju, R., & Chintagunta, P. K. (2004). Return on investment implications for pharmaceutical promotional expenditures: The role of marketing-mix interactions. Journal of Marketing, 68, 490–505.CrossRef
go back to reference Pazgal, A., Soberman, D., & D.A., & Thomadsen, R. (2016). Profit-increasing asymmetric entry. International Journal of Research in Marketing, 33, 107–122.CrossRef Pazgal, A., Soberman, D., & D.A., & Thomadsen, R. (2016). Profit-increasing asymmetric entry. International Journal of Research in Marketing, 33, 107–122.CrossRef
go back to reference Pierce, D. A. (1977). Relationships and the lack thereof between economic time series. Journal of the American Statistical Association, 72, 11–26. Pierce, D. A. (1977). Relationships and the lack thereof between economic time series. Journal of the American Statistical Association, 72, 11–26.
go back to reference Pinto, M. B. (2000). On the nature and properties of appeals used in direct-to-consumer advertising of prescription drugs. Psychological Reports, 86, 597–607.CrossRef Pinto, M. B. (2000). On the nature and properties of appeals used in direct-to-consumer advertising of prescription drugs. Psychological Reports, 86, 597–607.CrossRef
go back to reference Raju, J. S., & Roy, A. (2000). Market information and firm performance. Management Science, 46, 1075–1084.CrossRef Raju, J. S., & Roy, A. (2000). Market information and firm performance. Management Science, 46, 1075–1084.CrossRef
go back to reference Rizzo, J. A. (1999). Advertising and competition in the ethical pharmaceutical industry: The case of antihypertensive drugs. The Journal of Law and Economics, 42, 89–116.CrossRef Rizzo, J. A. (1999). Advertising and competition in the ethical pharmaceutical industry: The case of antihypertensive drugs. The Journal of Law and Economics, 42, 89–116.CrossRef
go back to reference Roth, M. S. (2003). Media and message effects on DTC prescription drug print advertising awareness. Journal of Advertising Research, 43, 180–193.CrossRef Roth, M. S. (2003). Media and message effects on DTC prescription drug print advertising awareness. Journal of Advertising Research, 43, 180–193.CrossRef
go back to reference Roy, A., & Raju, J. S. (2011). The influence of demand factors on dynamic competitive pricing strategy: An empirical study. Marketing Letters, 22, 259–281.CrossRef Roy, A., & Raju, J. S. (2011). The influence of demand factors on dynamic competitive pricing strategy: An empirical study. Marketing Letters, 22, 259–281.CrossRef
go back to reference Roy, A., Kim, N., & Raju, J. S. (2006). Assessing new empirical industrial organization (NEIO) methods: The cases of five industries. International Journal of Research in Marketing, 23, 369–383.CrossRef Roy, A., Kim, N., & Raju, J. S. (2006). Assessing new empirical industrial organization (NEIO) methods: The cases of five industries. International Journal of Research in Marketing, 23, 369–383.CrossRef
go back to reference Roy, A., Hanssens, D. M., & Raju, J. S. (1994). Competitive pricing by a price leader. Management Science, 40, 809–823.CrossRef Roy, A., Hanssens, D. M., & Raju, J. S. (1994). Competitive pricing by a price leader. Management Science, 40, 809–823.CrossRef
go back to reference Roy, A., & Schramm, M. E. (2020). The relationship between competitive pricing and direct-to-consumer advertising: How to manage DTC advertising of Rx drugs in an integrated marketing mix strategy. Journal of Advertising Research, 60(3), 305–323.CrossRef Roy, A., & Schramm, M. E. (2020). The relationship between competitive pricing and direct-to-consumer advertising: How to manage DTC advertising of Rx drugs in an integrated marketing mix strategy. Journal of Advertising Research, 60(3), 305–323.CrossRef
go back to reference Rust, R. T., & Schmittlein, D. C. (1985). A Bayesian cross-validated likelihood method for comparing alternative specifications of quantitative models. Marketing Science, 4, 375–393.CrossRef Rust, R. T., & Schmittlein, D. C. (1985). A Bayesian cross-validated likelihood method for comparing alternative specifications of quantitative models. Marketing Science, 4, 375–393.CrossRef
go back to reference Schramm, M. E., Herbst, J. L., & Mattie, A. (2014). The false claims act: A review and policy recommendations. International Journal of Pharmaceutical and Healthcare Marketing, 8, 295–313.CrossRef Schramm, M. E., Herbst, J. L., & Mattie, A. (2014). The false claims act: A review and policy recommendations. International Journal of Pharmaceutical and Healthcare Marketing, 8, 295–313.CrossRef
go back to reference Sridhar, S., Narayanan, S., & Srinivasan, R. (2014). Dynamic relationships among R&D, advertising, inventory and firm performance. Journal of the Academy of Marketing Science, 2, 277–290.CrossRef Sridhar, S., Narayanan, S., & Srinivasan, R. (2014). Dynamic relationships among R&D, advertising, inventory and firm performance. Journal of the Academy of Marketing Science, 2, 277–290.CrossRef
go back to reference Tyagi, R. K. (1999). Pricing patterns as outcomes of product positions. The Journal of Business, 72, 135–157.CrossRef Tyagi, R. K. (1999). Pricing patterns as outcomes of product positions. The Journal of Business, 72, 135–157.CrossRef
go back to reference Villas-Boas, M., & Zhao, Y. (2005). Retailer, manufacturers, and individual consumers: Modeling the supply side in the ketchup marketplace. Journal of Marketing Research, 41, 83–95.CrossRef Villas-Boas, M., & Zhao, Y. (2005). Retailer, manufacturers, and individual consumers: Modeling the supply side in the ketchup marketplace. Journal of Marketing Research, 41, 83–95.CrossRef
go back to reference Vuong, Q. H. (1989). Likelihood ratio tests for model selection and non-nested hypotheses. Econometrica, 57, 307–333.CrossRef Vuong, Q. H. (1989). Likelihood ratio tests for model selection and non-nested hypotheses. Econometrica, 57, 307–333.CrossRef
Metadata
Title
A dynamic model of price competition and promotion in prescription drug markets
Author
Abhik Roy
Publication date
22-04-2022
Publisher
Springer US
Published in
Marketing Letters / Issue 4/2022
Print ISSN: 0923-0645
Electronic ISSN: 1573-059X
DOI
https://doi.org/10.1007/s11002-022-09632-9